Atlas Trials

Study of Inactivated SARS-CoV-2 Vaccine (Vero Cells) in Healthy Population Aged 3 to 17 Years(COVID-19)

Clinical trial NCT05003466 · UNKNOWN

Trial details

NCT number
NCT05003466
Sponsor
Shenzhen Kangtai Biological Products Co., LTD
Status
UNKNOWN
Phase
Phase 2
Study type
INTERVENTIONAL
COVID-19
Start date
2021-09-01
Primary completion
2023-03-01
Enrollment
480

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.